Preethi Sundaram

Companies

• Catalyst PharmaceuticalsChief Product Devel. Officer Jul 13, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Catalyst Pharmaceuticals CPRX0 shares²Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 54,804 shares at $31.50 of Catalyst Pharmaceuticals²
• Dec 29, 2025Shares withheld for tax 2,369 shares of Catalyst Pharmaceuticals³
• Dec 29, 2025Exercised options 6,667 shares of Catalyst Pharmaceuticals³
• Dec 8, 2025Shares withheld for tax 1,669 shares of Catalyst Pharmaceuticals⁴
• Dec 8, 2025Exercised options 6,855 shares of Catalyst Pharmaceuticals⁴
• Nov 21, 2025Shares withheld for tax 1,364 shares of Catalyst Pharmaceuticals⁵
• Nov 21, 2025Exercised options 5,603 shares of Catalyst Pharmaceuticals⁵
• Jun 11, 2025Sold 1,600 shares at $26.42 of Catalyst Pharmaceuticals⁶
• Jun 10, 2025Sold 2,324 shares at $26.41 of Catalyst Pharmaceuticals⁶
• Feb 14, 2025Shares withheld for tax 5,965 shares of Catalyst Pharmaceuticals⁷
• Feb 14, 2025Exercised options 16,667 shares of Catalyst Pharmaceuticals⁷
• Dec 27, 2024Shares withheld for tax 2,345 shares of Catalyst Pharmaceuticals⁸
• Dec 27, 2024Exercised options 6,667 shares of Catalyst Pharmaceuticals⁸
• Dec 9, 2024Shares withheld for tax 2,415 shares of Catalyst Pharmaceuticals⁹
• Dec 9, 2024Exercised options 6,855 shares of Catalyst Pharmaceuticals⁹
• Feb 15, 2024Shares withheld for tax 6,025 shares of Catalyst Pharmaceuticals¹⁰
• Feb 15, 2024Exercised options 16,667 shares of Catalyst Pharmaceuticals¹⁰
• Dec 27, 2023Shares withheld for tax 2,409 shares of Catalyst Pharmaceuticals¹¹
• Dec 27, 2023Exercised options 6,666 shares of Catalyst Pharmaceuticals¹¹
• Feb 15, 2023Shares withheld for tax 6,024 shares of Catalyst Pharmaceuticals¹²
• Feb 15, 2023Exercised options 16,666 shares of Catalyst Pharmaceuticals¹²
• Nov 11, 2022Sold 28,393 shares at $16.50 of Catalyst Pharmaceuticals¹³
• Nov 11, 2022Sold 28,393 shares at $16.25 of Catalyst Pharmaceuticals¹³
• Nov 11, 2022Exercised options 56,786 shares at $5.49 of Catalyst Pharmaceuticals¹³
• Sep 15, 2022Sold 18,214 shares at $14.49 of Catalyst Pharmaceuticals¹⁴